Coker RK, Cullen KM. Sarcoidosis: key disease aspects and update on management. Clin Med. 2025;25(3):100326. https://doi.org/10.1016/j.clinme.2025.100326.
Aftab A, Szeto S, Aftab Z, Bokhari S. Cardiac sarcoidosis: diagnosis and management. Front Cardiovasc Med. 2024;11:1394075. https://doi.org/10.3389/fcvm.2024.1394075.
Article PubMed PubMed Central Google Scholar
Stjepanovic M, Markovic F, Milivojevic I, Popevic S, Dimic-Janjic S, Popadic V, Zdravkovic D, Popovic M, Klasnja A, Radojevic A, et al. Contemporary diagnostics of cardiac sarcoidosis: the importance of multimodality imaging. Diagnostics. 2024;14(17):1865. https://doi.org/10.3390/diagnostics14171865.
Article PubMed PubMed Central Google Scholar
Terasaki F, Azuma A, Anzai T, Ishizaka N, Ishida Y, Isobe M, Inomata T, Ishibashi-Ueda H, Eishi Y, Kitakaze M, Kusano K, Sakata Y, Shijubo N, Tsuchida A, Tsutsui H, Nakajima T, Nakatani S, Horii T, Yazaki Y, Yamaguchi E, Yamaguchi T, Ide T, Okamura H, Kato Y, Goya M, Sakakibara M, Soejima K, Nagai T, Nakamura H, Noda T, Hasegawa T, Morita H, Ohe T, Kihara Y, Saito Y, Sugiyama Y, Morimoto SI, Yamashina A, Japanese Circulation Society Joint Working Group. JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis - digest version. Circ J. 2019;83(11):2329–88. https://doi.org/10.1253/circj.CJ-19-0508.
Judson MA, Costabel U, Drent M, Wells A, Maier L, Koth L, Shigemitsu H, Culver DA, Gelfand J, Valeyre D, Sweiss N, Crouser E, Morgenthau AS, Lower EE, Azuma A, Ishihara M, Morimoto S, Tetsuo Yamaguchi T, Shijubo N, Grutters JC, Rosenbach M, Li HP, Rottoli P, Inoue Y, Prasse A, Baughman RP, Organ Assessment Instrument Investigators TW. The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis. 2014 Apr 18;31(1):19–27.
Birnie DH, Nery PB, Ha AC, Beanlands RS. Cardiac sarcoidosis. J Am Coll Cardiol. 2016;68(26):411–21. https://doi.org/10.1016/j.jacc.2016.03.605.
Crouser ED, Maier LA, Wilson KC, Bonham CA, Morgenthau AS, Patterson KC, Abston E, Bernstein RC, Blankstein R, Chen ES, Culver DA, Drake W, Drent M, Gerke AK, Ghobrial M, Govender P, Hamzeh N, James WE, Judson MA, Kellermeyer L, Knight S, Koth LL, Poletti V, Raman SV, Tukey MH, Westney GE, Baughman RP. Diagnosis and detection of sarcoidosis. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2020;201(8):e26–51. https://doi.org/10.1164/rccm.202002-0251ST.
Article PubMed PubMed Central Google Scholar
Uemura A, Morimoto S, Hiramitsu S, et al. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J. 1999;138:299–302.
Chareonthaitawee P, Beanlands RS, Chen W, et al. Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Cardiol. 2017;24(5):1741–58.
Dubrey SW, Falk RH. Diagnosis and management of cardiac sarcoidosis. Prog Cardiovasc Dis. 2010;52:336–46.
Jain H, Shahzad M, Usman M, Kc A, Singh J, Jain J, Odat RM, Goyal A, Ahmed F, Ahmed R. Detection of myocardial deformation patterns and prognostic value of routine echocardiographic parameters in patients with cardiac sarcoidosis versus extracardiac sarcoidosis: systematic review and meta-analysis. Diagnostics. 2025;15(5):518. https://doi.org/10.3390/diagnostics15050518.
Article PubMed PubMed Central Google Scholar
Mehta D, Lubitz SA, Frankel Z, et al. Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing. Chest. 2008;133(6):1426–35.
Chareonthaitawee P, Gutberlet M. Clinical utilization of multimodality imaging for myocarditis and cardiac sarcoidosis. Circ Cardiovasc Imaging. 2023;16(1):e014091. https://doi.org/10.1161/CIRCIMAGING.122.014091.
Yazaki Y, Isobe M, Hiroe M, et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol. 2001;88:1006–10.
Chiu C-Z, Nakatani S, Zhang G, et al. Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis. Am J Cardiol. 2005;95:143–6.
Casipit BA, Lo KB, Casipit CG, Idowu A, Amanullah A. Impact of comorbid heart failure among hospitalized patients with sarcoidosis: a United States population-based cohort study. IJC Heart Vasc. 2023;49:101275. https://doi.org/10.1016/j.ijcha.2023.101275.
Cameli P, Pastore MC, Mandoli GE, Vigna M, De Carli G, Bergantini L, d’Alessandro M, Ghionzoli N, Bargagli E, Cameli M. Strain echocardiography is a promising tool for the prognostic assessment of sarcoidosis. Life. 2021;11:1065. https://doi.org/10.3390/life11101065.
Article PubMed PubMed Central Google Scholar
Greulich S, Deluigi CC, Gloekler S, Wahl A, Zürn C, Kramer U, Nothnagel D, Bültel H, Schumm J, Grün S, Ong P, Wagner A, Schneider S, Nassenstein K, Gawaz M, Sechtem U, Bruder O, Mahrholdt H. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging. 2013;6(4):501–11. https://doi.org/10.1016/j.jcmg.2012.10.021.
Patel MR, Cawley PJ, Heitner JF, Klem I, Parker MA, Jaroudi WA, Meine TJ, White JB, Elliott MD, Kim HW, Judd RM, Kim RJ. Detection of myocardial damage in patients with sarcoidosis. Circulation. 2009;120(20):1969–77. https://doi.org/10.1161/CIRCULATIONAHA.109.851352.
Article PubMed PubMed Central Google Scholar
Puntmann VO, Isted A, Hinojar R, Foote L, Carr-White G, Nagel E. T1 and T2 mapping in recognition of early cardiac involvement in systemic sarcoidosis. Radiology. 2017;285(1):63–72. https://doi.org/10.1148/radiol.2017162732.
Kouranos V, Tzelepis GE, Rapti A, Mavrogeni S, Aggeli K, Douskou M, Prasad S, Koulouris N, Sfikakis P, Wells A, Gialafos E. Complementary role of CMR to conventional screening in the diagnosis and prognosis of cardiac Sarcoidosis. JACC Cardiovasc Imaging. 2017;10(12):1437–47. https://doi.org/10.1016/j.jcmg.2016.11.019.
Stevenson A, Bray JJH, Tregidgo L, Ahmad M, Sharma A, Ng A, Siddiqui A, Khalid AA, Hylton K, Ionescu A, Providencia R, Kirresh A. Prognostic value of late gadolinium enhancement detected on cardiac magnetic resonance in cardiac sarcoidosis. JACC Cardiovasc Imaging. 2023;16(3):345–57. https://doi.org/10.1016/j.jcmg.2022.10.018.
Vanchin B, Ka MM, Arendt CT, et al. Myocardial tissue changes detected by cardiac MRI in a patient with suspected systemic sarcoidosis. BMC Cardiovasc Disord. 2023;23:131. https://doi.org/10.1186/s12872-023-03133-x.
Article PubMed PubMed Central Google Scholar
Kim D, Collins JD, White JA, Hanneman K, Lee DC, Patel AR, Hu P, Litt H, Weinsaft JW, Davids R, Mukai K, Ng MY, Luetkens JA, Roguin A, Rochitte CE, Woodard PK, Manisty C, Zareba KM, Mont L, Bogun F, Ennis DB, Nazarian S, Webster G, Stojanovska J. SCMR expert consensus statement for cardiovascular magnetic resonance of patients with a cardiac implantable electronic device. J Cardiovasc Magn Reson. 2024;26(1):100995. https://doi.org/10.1016/j.jocmr.2024.100995.
Article PubMed PubMed Central Google Scholar
Athwal PSS, Chhikara S, Ismail MF, Ismail K, Ogugua FM, Kazmirczak F, Bawaskar PH, Elton AC, Markowitz J, von Wald L, Roukoz H, Bhargava M, Perlman D, Shenoy C. Cardiovascular magnetic resonance imaging phenotypes and long-term outcomes in patients with suspected cardiac sarcoidosis. JAMA Cardiol. 2022;7(10):1057–66. https://doi.org/10.1001/jamacardio.2022.2981.
Article PubMed PubMed Central Google Scholar
Crouser ED, Ruden E, Julian MW, Raman SV. Resolution of abnormal cardiac MRI T2 signal following immune suppression for cardiac sarcoidosis. J Investig Med. 2016;64(6):1148–50.
Futamatsu H, Suzuki J-I, Adachi S, Okada H, Otomo K, Ohara T, Hashimoto Y, Kakuta T, Iesaka Y, Yamaguchi H, et al. Utility of gallium-67 scintigraphy for evaluation of cardiac sarcoidosis with ventricular tachycardia. Int J Card Imag. 2005;22:443–8. https://doi.org/10.1007/s10554-005-9043-x.
Eguchi M, Tsuchihashi K, Hotta D, Hashimoto A, Sasao H, Yuda S, Nakata T, Shijubou N, Abe S, Shimamoto K. Technetium-99m sestamibi/tetrofosmin myocardial perfusion scanning in cardiac and noncardiac sarcoidosis. Cardiology. 2000;94(3):193–9. https://doi.org/10.1159/000047316.
Slart RHJA, Glaudemans AWJM, Gheysens O, Lubberink M, Kero T, Dweck MR, Habib G, Gaemperli O, Saraste A, Gimelli A, Georgoulias P, Verberne HJ, Bucerius J, Rischpler C, Hyafil F, Erba PA; 4Is Cardiovascular Imaging: a joint initiative of the European Association of Cardiovascular Imaging (EACVI); European Association of Nuclear Medicine (EANM). Procedural recommendations of cardiac PET/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation (4Is)-related cardiovascular diseases: a joint collaboration of the EACVI and the EANM. Eur J Nucl Med Mol Imaging. 2021 Apr;48(4):1016–1039. https://doi.org/10.1007/s00259-020-05066-5.Osborne
M T, Hulten, EA, Singh A, et al. Clinical value of hybrid cardiac PET/CT in cardiac sarcoidosis. JACC Cardiovascular Imaging. 2022;15(9): 1569–1582.
Kaneko K, Nagao M, Yamamoto A, Sakai A, Sakai S. FDG uptake patterns in isolated and systemic cardiac sarcoidosis. J Nucl Cardiol. 2023;30(3):1065–74. https://doi.org/10.1007/s12350-022-03106-1.
Comments (0)